Ata, Marissa .

HRN: 28-35-52  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/09/2026
CEFUROXIME 500MG (TAB)
01/09/2026
01/16/2026
PO
500mg
BID
RMLE
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines